PATENT CLAIM ANALYSIS

Application Number: 15867425
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "262100"]

Abstract:
The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, where R 1 -R 3  and Y are defined in the description, and its use in the treatment of disorders in which pi3 kinase is implicated.

Claim (Index 13):
The method of  claim 10 , wherein the respiratory condition is COPD.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14261890', '12180969', '12809394', '16060486', '14406848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.809394943109194
- 35 USC 102 Novelty (BERT): 0.5791433658730809
- Combined Prediction Score: 0.7863697853855827
- Mean Citation Score: 441.36409
- Max Citation Score: 561.0378
- Similarity Product: 342.55864233233933

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test